米軍退役軍人の認知機能低下:リスク要因と臨床的影響
Rob J MacLennan1,2, Benjamin A Chapin1,3,4, Laurence M Solberg1,5,6
1Geriatric Research, Education, and Clinical Center, North Florida/South Georgia Veterans Health System, Gainesville, FL, United States.
Frontiers in dementia
|February 19, 2026
まとめ
退役軍人は,軍務のため,民間人よりも認知機能低下のリスク要因に直面しています. 早期のスクリーニングと介入は,これらのリスクを管理し,ヘルスケアの負担を軽減するために不可欠です.
科学分野:
- ゲロントロジーはゲロントロジーの学科です.
- 公衆衛生は公衆衛生である.
- 神経科学は神経科学である.
背景:
- 退役軍人は,非退役軍人と比べて,認知機能低下の危険因子の有病率が高くなります.
- 独特の軍務経験と被曝は,リスク因子の有病率の格差に寄与する.
- アルツハイマー病やその他の認知症は,患者,家族,介護者,医療システムに重大な財政的および物流的負担を課します.
研究 の 目的:
- 退役軍人や非退役軍人の集団における認知機能低下リスク因子の有病率を提示する.
- 特に退役軍人の認知機能低下のリスク要因を管理するためのアプローチを提案する.
- 認知機能低下のリスク要因に対する早期スクリーニングと介入の重要性を強調する.
主な方法:
- ベテランと非ベテランの集団のリスク因子流行の比較分析.
- 兵役暴露と認知健康に関する既存の文献のレビュー.
- 退役軍人のための提案されたリスク管理戦略の開発.
主要な成果:
- 退役軍人は,糖尿病,慢性疼痛,喫煙,うつ病などの主要なリスク要因の総流行率が高くなります.
- 兵役は,これらの危険因子の増加に寄与する要因として特定されています.
- この研究は,退役軍人のための,個別化されたスクリーニングと介入プログラムの必要性を強調しています.
結論:
- 退役軍人の認知機能低下の危険因子に対する標準化された早期スクリーニングは不可欠です.
- リスク要因の積極的な管理は,認知機能低下の進行を緩和し,関連する医療負担を軽減することができます.
- 退役軍人のためのターゲットを絞ったアプローチを実装することで,認知健康の成果を向上させ,システムコストを軽減することができます.
関連する概念動画
Cognitive Development During Adulthood
943
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
943
Drug Dosing: Geriatric Patients
289
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
289
Dementia
591
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
591
Pharmacodynamics in Geriatric Patients: Effects of Age
253
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
253
Post-traumatic Stress Disorder
620
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
620
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K


